Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: RECCE PHARMACEUTICALS
Firm Income Reported for This Client
$632K
Not substituted for client expenses
Summary
RECCE PHARMACEUTICALS is an organization. Its political footprint includes $632K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Medical/Disease Research/Clinical Labs. Political activity spans from 2023 to 2026.